Survival of blacks and whites after a cancer diagnosis
View abstract on PubMed
Summary
This summary is machine-generated.Racial disparities in cancer survival are minimal when treatment and stage are comparable. Differences in cancer biology are unlikely to explain survival gaps; instead, focus on treatment and other health issues to reduce disparities.
Area Of Science
- Oncology
- Epidemiology
- Health Disparities Research
Background
- Observed poorer cancer survival rates in Black individuals compared to White individuals have fueled theories of inherent biological differences.
- However, the impact of differential treatment quality and comorbidities on these survival discrepancies has been underexplored.
Purpose Of The Study
- To quantify survival differences between Black and White patients receiving equivalent cancer treatment for similar disease stages.
- To investigate the extent to which cancer biology, rather than other factors, contributes to observed racial survival gaps.
Main Methods
- Systematic literature search of MEDLINE (1966-2002) for studies comparing Black and White cancer patient survival with similar treatment.
- Inclusion criteria: studies reporting on at least 10 Black and 10 White patients, comparable treatment, stage-adjusted survival data.
- Meta-analysis of overall and cancer-specific survival using hazard ratios (HRs), adjusted for non-cancer mortality.
Main Results
- Analysis of 189,877 White and 32,004 Black patients across 14 cancer types.
- Black patients had a slightly higher overall risk of death (HR=1.16) compared to White patients.
- After adjusting for non-cancer deaths, the cancer-specific risk of death was marginally higher for Black patients (HR=1.07), significant only for breast, uterine, and bladder cancers.
Conclusions
- Modest cancer-specific survival differences exist between racial groups when treatment and stage are comparable, suggesting cancer biology is not a major driver of disparities.
- Discrepancies in treatment, disease stage at diagnosis, and mortality from other health conditions are more likely explanations for survival gaps.
- Interventions should target these modifiable factors to effectively reduce cancer outcome disparities.